The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase

Jennie O’ Loughlin(University College Dublin), Marina Rubini(University College Dublin), Fahad Alkhathami(University College Dublin), Cillian O’Beirne(University College Dublin), Orla Howe(Nottingham University Hospitals NHS Trust), Silvia Napolitano(ETH Zurich), Megan O’Shaughnessy(University of Liverpool), Matthias Tacke(University College Dublin), D. Marhöfer(University College Dublin)
ChemBioChem
November 10, 2020
10.1002/cbic.202000707
Cited by 25

Related Papers

Porous isoreticular non-metal organic frameworks
|Nature|2024|131
Disarming Pseudomonas aeruginosa Virulence by the Inhibitory Action of 1,10-Phenanthroline-5,6-Dione-Based Compounds: Elastase B (LasB) as a Chemotherapeutic Target
|Frontiers in Microbiology|2019|58
The Antibacterial and Anti-Biofilm Activity of Metal Complexes Incorporating 3,6,9-Trioxaundecanedioate and 1,10-Phenanthroline Ligands in Clinical Isolates of Pseudomonas aeruginosa from Irish Cystic Fibrosis Patients
|Antibiotics|2020|29
Controlling the Crystallisation and Hydration State of Crystalline Porous Organic Salts
|Chemistry - A European Journal|2023|21
The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs
|International Journal of Molecular Sciences|2023|19